Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neurophobia Experienced by Medical Students in India
Education, Research, and Methodology
P10 - Poster Session 10 (11:45 AM-12:45 PM)
7-008
Neurophobia is defined as the fear of neuroscience and neurology among medical trainees and professionals, namely medical students. To our knowledge, this analysis is the first that aimed to quantify neurophobia among Indian medical students.

The objective of this study was to investigate factors associated with neurophobia among medical trainees in India.

A 16-question standardized email survey was administered to medical trainees at various private and governmental medical institutions in India. The target sample population included MBBS students, MBBS graduates, and DNB/MD/Diploma students. A total of 1,227 respondents were included in our statistical analysis, calculated in R studio. Respondents were stratified into those with and without self-identified neurophobia. Proportions of baseline characteristics between the two groups were compared via chi-square or Wilcoxon signed-rank tests. A multivariate logistic regression model was used to determine the relative odds of each factor's contribution to neurophobia.

Factors that demonstrated less risk of neurophobia were male sex (odds ratio (OR): 0.77, p=0.049), excellent neurology knowledge level (OR: 0.23, p=0.00066), good neurology knowledge level (OR: 0.34, p<0.0001), neurology taught by a neurologist (OR: 0.72, p= 0.047), and good quality of neurology instruction (OR: 0.56, p= 0.00053). Variables that increased risk of neurophobia in respondents were poor neurology knowledge level (OR: 2.39, p<0.00001), very poor neurology knowledge level (OR: 1.96, p=0.014), private sector placement (OR: 1.40, p=0.0086), below average quality of neurology instruction (OR: 1.54, p= 0.013), and poor quality of neurology instruction (OR: 1.78, p= 0.011).

Factors that were associated with an increased risk of neurophobia were found to be female gender, poor and very poor neurology knowledge level, private sector placement, below average quality of neurology instruction, and poor quality of neurology instruction. We encourage further studies to analyze factors associated with neurophobia as well as address neurophobia gender discrepancies in medical and academic settings.

Authors/Disclosures
Hayes Fountain
PRESENTER
No disclosure on file
Tiffany A. Eatz (University of Miami Miller School of Medicine) Ms. Eatz has nothing to disclose.
Ahamed Subir Humyum Kabir (MES Medical College) No disclosure on file
Ian Ramsay No disclosure on file
Maxon Knott (University of Miami Miller School of Medicine) No disclosure on file
Venkata Sai Manikant Sanikommu No disclosure on file
Ahmed Abdelsalam (University of Miami Miller school of medicine) No disclosure on file
Eva Wu No disclosure on file
Robert Starke No disclosure on file
Dileep R. Yavagal, MD, FAAN (University of Miami Miller School of Medicine) Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.